SINOPHARM GRP CO. H YC 1SINOPHARM GRP CO. H YC 1SINOPHARM GRP CO. H YC 1

SINOPHARM GRP CO. H YC 1

No trades
See on Supercharts

Price target

2.700.000.00%
The 13 analysts offering 1 year price forecasts for X2S have a max estimate of — and a min estimate of —.

Analyst rating

Based on 16 analysts giving stock ratings to X2S in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


X2S EPS for the last quarter is 0.15 EUR despite the estimation of 0.18 EUR. In the next quarter EPS is expected to reach 0.19 EUR. Track more of SINOPHARM GRP CO. H YC 1 financials and stay on top of what is up with the company.
In the next quarter SINOPHARM GRP CO. H YC 1 revenue is expected to reach ‪39.80 B‬ EUR. Check out SINOPHARM GRP CO. H YC 1 revenue and earnings and make informed decisions.
According to analysts, X2S price target is 2.70 EUR with a max estimate of 3.38 EUR and a min estimate of 1.77 EUR. Check if this forecast comes true in a year, meanwhile watch SINOPHARM GRP CO. H YC 1 stock price chart and keep track of the current situation with X2S news and stock market news.
We've gathered opinions of 16 analysts rating X2S stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.